• Study shows NOV03 safe, effective for dry eye

    12 days ago - By Healio

    NOV03 treatment was found to reduce signs and symptoms of dry eye disease in a phase 2 clinical study.
    “An improved tolerability profile versus currently available therapies is important for the clinical management of DED in practice, considering that up to 60% of patients stop their therapy within 12 months,” wrote Joseph Tauber, MD, of the Tauber Eye Center, and colleagues.
    Researchers conducted a randomized, double-masked, saline-controlled clinical study to evaluate the safety, efficacy and tolerability of NOV03 compared to saline. Three hundred thirty-six DED
    Read more ...